$10.56 (0.380%)

Volume: 601.5k

Closed: Jan 27, 2023

Hollow Logo Score: 0.195
Anavex Life Sciences Corp. Stock
$10.56 (0.380%)

Volume: 601.5k

Closed: Jan 27, 2023

Score Hollow Logo 0.195

Anavex Life Sciences Corp. Stock Forecast

Updated Fri, Jan 27, 2023
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Be the first to comment on AVXL

Green day on Friday for Anavex Life Sciences Corp. stock after gaining 0.38%
(Updated on Jan 27, 2023)

Buy or Hold candidate since 2023-01-24 Loss -1.49% PDF

The Anavex Life Sciences Corp. stock price gained 0.380% on the last trading day (Friday, 27th Jan 2023), rising from $10.52 to $10.56. During the last trading day the stock fluctuated 2.69% from a day low at $10.41 to a day high of $10.69. The price has been going up and down for this period, and there has been a -5.8% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 602 thousand shares were bought and sold for approximately $6.35 million.

Give Options Surge a try today. And start trading with the pros, instead of behind them.* >>

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $10.75 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -20.85% during the next 3 months and, with a 90% probability hold a price between $4.88 and $8.51 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

AVXL Signals & Forecast

The Anavex Life Sciences Corp. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $10.49 and $9.47. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, January 12, 2023, and so far it has fallen -5.80%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Here's how to open broker account if you're new to investing.

Support, Risk & Stop-loss for Anavex Life Sciences Corp. stock

On the downside, the stock finds support just below today's level from accumulated volume at $9.58 and $9.10. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Anavex Life Sciences Corp. finds support just below today's level at $9.58. If this is broken, then the next support from accumulated volume will be at $9.10 and $8.38.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.280 between high and low, or 2.69%. For the last week, the stock has had daily average volatility of 4.92%.

Our recommended stop-loss: $10.03 (-5.00%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 10 days ago.)

Trading Expectations (AVXL) For The Upcoming Trading Day Of Monday 30th

For the upcoming trading day on Monday, 30th we expect Anavex Life Sciences Corp. to open at $10.55, and during the day (based on 14 day Average True Range), to move between $9.93 and $11.19, which gives a possible trading interval of +/-$0.634 (+/-6.01%) up or down from last closing price. If Anavex Life Sciences Corp. takes out the full calculated possible swing range there will be an estimated 12.02% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $10.58 (0.19%) than the support at $9.58 (9.28%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Anavex Life Sciences Corp. stock A Buy?

Anavex Life Sciences Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.195 Open Broker Account

Hold/Accumulate Unchanged

Predicted Opening Price for Anavex Life Sciences Corp. of Monday, January 30, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price January 30, 2023 Current price
$10.55 $10.56 (Overvalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 10.83 2.59 %
R2 10.73 1.58 %
R1 10.66 0.95 %
Current price: 10.56
Support S1 10.45 -1.08 %
S2 10.38 -1.70 %
S3 10.27 -2.71 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 12.05 14.11 %
R2 11.21 6.16 %
R1 10.58 0.189 %
Current price 10.56
Support S1 9.58 -9.28%
S2 9.10 -13.83%
S3 8.38 -20.64%

Click to get the best stock tips daily for free!

Hot Stocks To Watch:

About Anavex Life Sciences Corp.

Anavex Life Sciences Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE